REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/28/2025
Back to search
Official data from USPTO
J-BRAIN CARGO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
J-BRAIN CARGO
ST13
US500000079261460Class
1, 5, 10, 40, 42, 44
Filing
79261460
Registration
6039338
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
04/29/2025
Trademark type
Word
Nice classes
1, 5, 10, 40, 42, 44
Filing date
03/28/2019
Registration date
04/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2020
Last transaction
04/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
CAYSIDO, REBECCA
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
JCR PHARMACEUTICALS CO., LTD.
Representatives
Christopher I. Donahue OBLON MCCLELLAND MAIER & NEUSTADT LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic reagents for scientificlaboratoryanalysisresearchtestinginspectiondetecting or verification useexcept for medical or veterinary use; biochemicalsmonoclonal antibodies for in vitro scientific or research use and antibodies-based chemicals for use in industry and scienceexcept for medical or veterinary use; chemicals for industrial purposesfor use in biotechnological product developmentfor use in industry and science
Class 5
Reagents for diagnostic medical purposes and veterinary purposes; diagnostic antibodies for use in disease testing and antibodies-based pharmaceutical preparations for medical purposes or veterinary purposes for testing of body fluids and for blood analysisurine analysissaliva analysis; pharmaceutical preparations for treating central nervous system disordersgenetic diseaseslysosomal diseasesauto-immune diseasesfor use in enzyme replacement therapies
Class 10
Medical apparatus and instrumentsinjection devices for pharmaceuticalsmedical apparatus for introducing pharmaceutical preparations into the human body
Class 40
Custom manufacture of pharmaceuticals or chemicals; custom manufacture of antibodies and antibodies-based pharmaceuticals or chemicals
Class 42
Medical research; chemical research; chemistry serviceschemistry consultation or research in the field of chemistry; chemical analysis; conducting clinical trials for others; testinginspection or research of pharmaceuticals; testing or research on machinesapparatus and instrumentstesting the functionality of machinesapparatus and instrumentstechnology research in the field of medical apparatus and instruments
Class 44
Physical examination services in the field of blood-brain barrier medical treatment; rental of medical machines and apparatus in the field of blood-brain barrier medical treatment
Publications
History of USPTO decisions and trademark events.
32 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/26/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/07/2020
FIMP
FINAL DISPOSITION PROCESSED
09/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2020
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2020
PUBO
PUBLISHED FOR OPPOSITION
02/11/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/29/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/29/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/17/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/16/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/16/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/28/2019
GNFR
FINAL REFUSAL E-MAILED
10/28/2019
CNFR
FINAL REFUSAL WRITTEN
10/28/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2019
ALIE
ASSIGNED TO LIE
10/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/25/2019
RFNT
REFUSAL PROCESSED BY IB
08/16/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/30/2019
RFRR
REFUSAL PROCESSED BY MPU
07/30/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/03/2019
CNRT
NON-FINAL ACTION WRITTEN
07/02/2019
MAFR
APPLICATION FILING RECEIPT MAILED
07/02/2019
DOCK
ASSIGNED TO EXAMINER
06/26/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/26/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/20/2019
Continuous trademark protection
Get notified about every new filing that threatens J-BRAIN CARGO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.